Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials
Top Story
Archived
•
November 24, 2025
•
The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.
Source: https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



